Colgate-Palmolive Company (NYSE:CL) Stock Has Average Target Price of $101.22

Colgate-Palmolive logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts rate Colgate-Palmolive “Moderate Buy”: Of 20 covering firms, 13 recommend buying and seven say hold; the average one-year price target is $101.22.
  • The company beat quarterly estimates, reporting EPS of $0.97 versus $0.93 expected and revenue of $5.37 billion versus $5.34 billion. Revenue rose 4.6% year over year.
  • Colgate-Palmolive’s quarterly dividend was $0.53 per share, equivalent to $2.12 annualized and a 2.1% yield.
  • MarketBeat previews the top five stocks to own by December 1st.

Shares of Colgate-Palmolive Company (NYSE:CL - Get Free Report) have earned an average rating of "Moderate Buy" from the twenty ratings firms that are currently covering the company, MarketBeat.com reports. Seven analysts have rated the stock with a hold rating and thirteen have issued a buy rating on the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $101.22.

Several equities analysts have recently commented on CL shares. Deutsche Bank restated a "buy" rating and issued a $101.00 price objective (up from $99.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. UBS Group increased their target price on Colgate-Palmolive from $106.00 to $112.00 and gave the stock a "buy" rating in a research note on Monday, November 2nd. Weiss Ratings cut Colgate-Palmolive from a "buy (b-)" rating to a "hold (c+)" rating in a report on Friday, October 2nd. Bank of America lifted their target price on Colgate-Palmolive from $100.00 to $105.00 and gave the company a "buy" rating in a research report on Monday, November 2nd. Finally, BNP Paribas Exane reiterated an "outperform" rating and set a $108.00 price target (up from $97.00) on shares of Colgate-Palmolive in a research note on Monday, November 2nd.

Read Our Latest Stock Analysis on CL

Colgate-Palmolive Stock Down 1.3%

Shares of CL opened at $99.63 on Wednesday. Colgate-Palmolive has a 52-week low of $75.96 and a 52-week high of $101.81. The company has a quick ratio of 0.63, a current ratio of 0.96 and a debt-to-equity ratio of 11.23. The stock has a fifty day simple moving average of $91.40 and a two-hundred day simple moving average of $90.44. The company has a market capitalization of $79.20 billion, a PE ratio of 39.07, a price-to-earnings-growth ratio of 4.57 and a beta of 0.31.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings results on Friday, October 30th. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.93 by $0.04. The business had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.34 billion. Colgate-Palmolive had a net margin of 9.65% and a return on equity of 607.88%. The business's revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.91 EPS. As a group, equities analysts forecast that Colgate-Palmolive will post 3.92 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th were paid a $0.53 dividend. The ex-dividend date of this dividend was Tuesday, October 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.1%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 83.14%.

Insider Buying and Selling at Colgate-Palmolive

In related news, CEO Noel Wallace sold 20,000 shares of the company's stock in a transaction that occurred on Thursday, November 5th. The shares were sold at an average price of $100.26, for a total transaction of $2,005,200.00. Following the sale, the chief executive officer directly owned 359,700 shares of the company's stock, valued at $36,063,522. This represents a 5.27% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Gregory Malcolm sold 4,100 shares of the stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $97.97, for a total transaction of $401,677.00. Following the sale, the executive vice president owned 10,061 shares in the company, valued at approximately $985,676.17. This trade represents a 28.95% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 77,414 shares of company stock worth $7,613,786. 0.43% of the stock is currently owned by company insiders.

Institutional Trading of Colgate-Palmolive

Large investors have recently made changes to their positions in the company. Virginia Estate & Retirement Planning Advisors Inc. increased its stake in shares of Colgate-Palmolive by 1,409.1% in the 3rd quarter. Virginia Estate & Retirement Planning Advisors Inc. now owns 332 shares of the company's stock valued at $28,000 after acquiring an additional 310 shares in the last quarter. Parvin Asset Management LLC acquired a new stake in shares of Colgate-Palmolive in the 2nd quarter valued at about $32,000. Park Place Capital Corp increased its position in Colgate-Palmolive by 55.5% in the 2nd quarter. Park Place Capital Corp now owns 356 shares of the company's stock valued at $33,000 after buying an additional 127 shares in the last quarter. Gould Capital LLC increased its position in Colgate-Palmolive by 38.7% in the 1st quarter. Gould Capital LLC now owns 412 shares of the company's stock valued at $35,000 after buying an additional 115 shares in the last quarter. Finally, Montgomery Financial Services LLC acquired a new position in Colgate-Palmolive during the 2nd quarter worth approximately $36,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

About Colgate-Palmolive

(Get Free Report)

Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company's best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill's Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.

Further Reading

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines